Cargando…

Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy

OBJECTIVES: Our aim was to improve the prediction of unfavorable histopathology (UH) in neuroblastic tumors through combined imaging and biochemical parameters. METHODS: (123)I-MIBG SPECT and MRI was performed before surgical resection or biopsy in 47 consecutive pediatric patients with neuroblastic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fendler, Wolfgang Peter, Wenter, Vera, Thornton, Henriette Ingrid, Ilhan, Harun, von Schweinitz, Dietrich, Coppenrath, Eva, Schmid, Irene, Bartenstein, Peter, Pfluger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503303/ https://www.ncbi.nlm.nih.gov/pubmed/26177109 http://dx.doi.org/10.1371/journal.pone.0132809

Ejemplares similares

Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy
por: Wenter, Vera, et al.
Publicado: (2017)

Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET/CT for nodal recurrence in prostate cancer patients
por: Herlemann, Annika, et al.
Publicado: (2017)

Discrimination of histopathologic types of childhood peripheral neuroblastic tumors based on clinical and biological factors
por: Yang, Shen, et al.
Publicado: (2018)

Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
por: Ahmaddy, Freba, et al.
Publicado: (2020)

Initial Evaluation of Therapy Response after Adjuvant Radioiodine Therapy in Patients with Early-Stage Papillary Thyroid Cancer—Does Time Matter?
por: Grawe, Freba, et al.
Publicado: (2022)

The diagnostic challenge of coexistent sarcoidosis and thyroid cancer – a retrospective study
por: Wenter, Vera, et al.
Publicado: (2021)

Salvage PRRT with (177)Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
por: Rudisile, S., et al.
Publicado: (2019)

Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
por: Wenter, Vera, et al.
Publicado: (2020)

(18)F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
por: Ahmaddy, Freba, et al.
Publicado: (2021)

Feasibility of Different Tumor Delineation Approaches for (18)F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy
por: Ilhan, Harun, et al.
Publicado: (2016)

Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
por: Grawe, Freba, et al.
Publicado: (2021)

Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors
por: Tadeo, Irene, et al.
Publicado: (2016)

Management of Primary Thoracic Neuroblastic Tumors in Children: An Observational Study
por: Shanmugam, Vivek, et al.
Publicado: (2022)

Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment
por: Hegemann, Nina-Sophie, et al.
Publicado: (2016)

Nucleofection of Rodent Neuroblasts to Study Neuroblast Migration In vitro
por: Falenta, Katarzyna, et al.
Publicado: (2013)

Morphologic Alteration of Metastatic Neuroblastic Tumor in Bone Marrow after Chemotherapy
por: Bae, Go Eun, et al.
Publicado: (2013)

Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma
por: He, Wen-Guang, et al.
Publicado: (2017)

Prognostic Value of c-MYC Expression in Patients with Peripheral Neuroblastic Tumors
por: Zhang, Feng, et al.
Publicado: (2021)

Investigation of image-based lesion and kidney dosimetry protocols for (177)Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition
por: Resch, Sandra, et al.
Publicado: (2023)

Major Signaling Pathways in Migrating Neuroblasts
por: Khodosevich, Konstantin, et al.
Publicado: (2009)

A Confidence Habitats Methodology in MR Quantitative Diffusion for the Classification of Neuroblastic Tumors
por: Cerdá Alberich, Leonor, et al.
Publicado: (2020)

Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors
por: Clement, Sarah C., et al.
Publicado: (2022)

[(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation
por: Wenter, Vera, et al.
Publicado: (2016)

Pediatric hepatocellular carcinoma: challenges and solutions
por: Schmid, Irene, et al.
Publicado: (2017)

Coopted temporal patterning governs cellular hierarchy, heterogeneity and metabolism in Drosophila neuroblast tumors
por: Genovese, Sara, et al.
Publicado: (2019)

Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature
por: Deslarzes, Philip, et al.
Publicado: (2022)

Preliminary experience with dosimetry, response and patient reported outcome after (177)Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer
por: Fendler, Wolfgang P., et al.
Publicado: (2016)

The Role of Somatostatin Receptor Scintigraphy on the Diagnosis of Desmoid Tumors
por: Friesenbichler, Joerg, et al.
Publicado: (2012)

Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer
por: Sirtl, Simon, et al.
Publicado: (2021)

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2018)

Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis
por: Gershon, Timothy R., et al.
Publicado: (2009)

Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data
por: Tabyaoui, Imane, et al.
Publicado: (2013)

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors
por: Veschi, V, et al.
Publicado: (2014)

Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
por: Chayka, Olesya, et al.
Publicado: (2015)

Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors
por: Gassenmaier, Sebastian, et al.
Publicado: (2020)

Erratum: Neuroblastic tumors of the adrenal gland in elderly patients: A case report and review of the literature
Publicado: (2023)

Identification and validation of radiomic features from computed tomography for preoperative classification of neuroblastic tumors in children
por: Zhao, Lian, et al.
Publicado: (2023)

Computed tomography-based radiomics to assess risk stratification in pediatric malignant peripheral neuroblastic tumors
por: Wang, Xiaoxia, et al.
Publicado: (2023)

Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7rr223qe7aeci4fo7ujcb1ren